ArticleScientific reports2025
Molecular dynamics study of host-guest interactions between anticancer drugs and Cucurbit[8]uril nanocontainer.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cucurbit[n]urils (CB[n]s) are synthetic molecular containers with unique structural features, containing hydrophobic cavities and polar carbonyl portals. They have widespread applications in various scientific fields, such as drug delivery systems. Paclitaxel (PTX) and Camptothecin (CPT) are natural compounds extensively used as chemotherapy drugs due to their antitumor activity. However, their application is limited by severe side effects and poor aqueous solubility. Consequently, numerous studies have been conducted to overcome these limitations. Several studies have shown that the CB[n] family, especially CB[7], and their derivatives can form stable inclusion complexes with hydrophobic drugs, thereby increasing their solubility in aqueous environments. In this research, molecular docking procedure and molecular dynamics (MD) simulations were utilized to consider the interaction details of PTX and CPT with CB[8]. The results indicate that CB[8] is capable of forming inclusion complexes with both PTX and CPT not only in a 1:1 ratio but also, due to the appropriate cavity size, in a 1:2 stoichiometry, primarily driven by the release of high-energy water molecules from within the CB[8] cavity into the bulk phase. Furthermore, the results suggest the possibility of π-π interactions between the two trapped drugs within the CB[8] cavity during the MD simulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.